New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ginkgo Bioworks Holdings, Inc.
DNA
Shape
US Flag

NYSE

Unprofitable

Unprofitable

816M

Biotechnology

Next Earning date - 06 Mar 2025

816M

Biotechnology

Next Earning date - 06 Mar 2025

14.25USD

Shape0.57 ( 4.17%)
Market Closed (as of Feb 08, 01:00 EDT)
favorite-chart

Relative Strenght

95
favorite-chart

Volume Buzz

11%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

78%

Quote Panel

Shape
Updated February 9, 2025
1W 10.89 % 1M 45.71 % 3M 62.67 % 1Y -76.41 %

Key Metrics

Shape
  • Market Cap

    816.36M


  • Shares Outstanding

    57.48M


  • Share in Float

    46.40M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    14.25


  • Average Volume

    1.50M


  • Beta

    1.098


  • Range

    5.26-64.4


  • Industry

    Biotechnology


  • Website

    https://www.ginkgobioworks.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.75x

P/S Ratio

0.93x

P/B Ratio

0.6

Debt/Equity

-298.8%

Net Margin

$-12.9

EPS

How DNA compares to sector?

P/E Ratio

Relative Strength

Shape

DNA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$204M

Shape129%

2025-Revenue

$5.81

Shape-438%

2025-EPS

$204M

Shape-467%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

BTIG

downgrade

Previous: Buy

2024-05-15

Now: Sell

William Blair

downgrade

Previous: Not converted

2024-05-10

Now: Underperform

CLSA

downgrade

Previous: Not converted

2022-08-16

Now: Sell

Bank of America Securities

downgrade

Previous: Not converted

2022-05-18

Now: Underperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.04
vs -0.01

Q1.23

arrow
arrow

N/A

-0.08
vs -0.05

Q2.23

arrow
arrow

N/A

-0.09
vs -0.41

Q3.23

arrow
arrow

N/A

-0.09
vs -0.40

Q4.23

arrow
arrow

N/A

-0.09
vs -0.04

Q1.24

arrow
arrow

N/A

-0.08
vs -0.08

Q2.24

arrow
arrow

N/A

-3.20
vs -0.09

Q3.24

arrow
arrow

N/A

-1.08
vs -0.09

Q4.24

arrow
arrow

N/A

-1.50
vs -0.09

Q1.25

arrow
arrow

N/A

-1.60
vs -0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-34%

98.3M  vs 148.5M

Q1.23

arrow
arrow

-52%

80.7M  vs 168.4M

Q2.23

arrow
arrow

-44%

80.6M  vs 144.6M

Q3.23

arrow
arrow

-17%

55.4M  vs 66.4M

Q4.23

arrow
arrow

-65%

34.8M  vs 98.3M

Q1.24

arrow
arrow

-53%

37.9M  vs 80.7M

Q2.24

arrow
arrow

-30%

56.2M  vs 80.6M

Q3.24

arrow
arrow

+61%

89M  vs 55.4M

Q4.24

arrow
arrow

+28%

44.5M  vs 34.8M

Q1.25

arrow
arrow

+17%

44.4M  vs 37.9M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-10%

-0.10
vs -0.47

Q1.23

arrow
arrow

-13%

-0.13
vs -0.10

Q2.23

arrow
arrow

-12%

-0.12
vs -0.13

Q3.23

arrow
arrow

-24%

-0.24
vs -0.12

Q4.23

arrow
arrow

-19%

-0.19
vs -0.24

Q1.24

arrow
arrow

-17%

-0.17
vs -0.19

Q2.24

arrow
arrow

-26%

-0.26
vs -0.17

Q3.24

arrow
arrow

-7%

-0.07
vs -0.26

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

342

342
vs 293

17%

Q1.23

arrow
arrow

322

322
vs 342

-6%

Q2.23

arrow
arrow

324

324
vs 322

1%

Q3.23

arrow
arrow

358

358
vs 324

10%

Q4.23

arrow
arrow

353

353
vs 358

-1%

Q1.24

arrow
arrow

346

346
vs 353

-2%

Q2.24

arrow
arrow

320

320
vs 346

-8%

Q3.24

arrow
arrow

7

7
vs 320

-98%

Earnings Growth

Latest News